Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NVS
TMO
Add up to 3 more stocks
NVS
Novartis AG
-0.04%
$141.00-0.05Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$268.00B
52W Range
$121.57 - $170.46
TMO
Thermo Fisher Scientific Inc.
+0.35%
$654.80+2.29Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$242.11B
52W Range
$435.27 - $683.63
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 21.27 | 35.22 |
| Forward P/E | 16.02 | 26.08 |
| PEG Ratio | 1.38 | 16.69 |
| P/B Ratio | 6.45 | 4.60 |
| P/S Ratio | 4.82 | 5.23 |
| P/FCF Ratio | 16.94 | 33.08 |
| EV/EBITDA | 13.85 | 26.39 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 74.4% | 41.0% |
| Operating Margin | 30.5% | 18.0% |
| Net Margin | 22.9% | 15.1% |
| ROE | 30.7% | 13.3% |
| ROA | 10.5% | 6.2% |
| ROIC | 13.9% | 7.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.86 | 1.55 |
| Quick Ratio | 0.67 | 1.18 |
| Debt/Equity | 1.18 | 0.81 |
| Interest Coverage | 14.38 | 5.71 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 3.4% | 0.3% |
| Payout Ratio | 71.5% | 9.7% |
| Yrs of Dividend Growth | 1 | 8 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.